Global Fibrinogen Concentrates Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 5.9% during a forecast period.

Global Fibrinogen Concentrates Market

(The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.)

Market Definition

The main contributing factor to this market is the growing incidence of bleeding disorders and an upsurge in the number of approvals associated to fibrinogen concentrate. The congenital fibrinogen deficiency segment is projected to grow at a CAGR of XX% for the duration of the forecast duration. The North America region was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027.

Market Dynamics

Fibrinogen is a soluble plasma glycoprotein. It is one of the blood clotting factors which are vital for blood clot formation. Fibrinogen pays attention is detailed for the treatment of acute bleeding incidents in patients with congenital fibrinogen deficiency, with afibrinogenemia and hypofibrinogenemia. It is a glycoprotein in vertebrates used as a medicinal drug for a blood disorder, which helps within the formation of blood clots. In severely bleeding patients, fibrinogen concentrate drastically improves whole blood clot firmness and decreases the postoperative transfusion necessities. The factors together with the upsurge in the use of fibrinogen pay attention to bleeding patients and for the treatment of congenital deficiencies propel the growth of the global market.

Besides, the upward thrust in consciousness and issues referring to the health enhance the growth of the market. The upsurges in demand for fibrinogen concentrates, a rise in the range of instances of bleeding issues, and the increase in obtainability of fibrinogen products are the main factors anticipated to thrust the global fibrinogen concentrates marketplace.

However, certain negative reactions including arterial thrombosis, chills, dyspnea, nausea, vomiting, and pulmonary embolism confine the growth.

Global Fibrinogen concentrates Market Segment analysis

Based at the Application, the congenital fibrinogen deficiency segment is projected to grow at a CAGR of XX% for the duration of the forecast duration. Congenital Fibrinogen Deficiency is predicted to register a higher increase in the fibrinogen concentrate marketplace as a result of the better occurrence of hemophilia and improvement in products associated with fibrinogen. According to the National Hemophilia Foundation, the worldwide prevalence of hemophilia is not well known, but estimated at more than 400,000 people. Nearly 75% of people with hemophilia around the world still receive inadequate treatment or have no access to treatment market. Biotest’s fibrinogen concentrate is presently being investigated clinically in a multinational segment I/III trial in sufferers with congenital fibrinogen deficiency. For the acquired fibrinogen deficiency Biotest conducts a Phase III examine in multiple European nations in patients with high blood loss throughout spine surgery. Therefore, the growing occurrence of bleeding problems and the safety and efficiency of human fibrinogen concentrate is anticipated to thrust the fibrinogen concentrate market growth in this segment.

Global Fibrinogen concentrates Market Regional analysis

North America is projected to account for the largest market share during the forecast period. The U.S. is expected to account for the largest market share in North America, followed by Canada. Approximately 18,000 people are living with hemophilia in the United States. The market within the region is predicted to be compelled by an upsurge in focus on developing new treatment plans for rare blooding clotting issues and refining access to orphan drugs which are indicated for the treatment of rare diseases.

Europe is probable to gain market share during the forecast length because of an upsurge in the number of market players presenting plasma-derived fibrinogen and an increase in the acceptance of new treatments in Germany, France, and the U.K. the fibrinogen concentrates. Acquired hemophilia, an unprecedented autoimmune disorder, is moderately predominant in the aged populace.

Octapharma has introduced the booklet of recent information demonstrating that the fibrinogen pay attention fibryga® is an effective opportunity to cryoprecipitate for patients with severe bleeding at some stage in cardiac surgery. The statistics have been recently posted inside the Journal of the American Medical Association (JAMA) in 31st Oct 2019.

Recent industry developments

15 March 2018 -Biotest AG today announces that the first patient in the pivotal phase III study in patients with acquired fibrinogen deficiency (study no. 995) has been treated.

The objective of the report is to present a comprehensive analysis of the Global Fibrinogen concentrates Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Fibrinogen concentrates Market dynamics; structure by analysing the market segments and projects the Global Fibrinogen concentrates Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Fibrinogen concentrates Market make the report investor’s guide.

Scope of the Global Fibrinogen concentrates Market

Global Fibrinogen concentrates Market, By Type

• Human Fibrinogen Concentrates

• Animal Fibrinogen Concentrates

Global Fibrinogen concentrates Market, By Application

• Congenital Fibrinogen Deficiency

• Surgical Procedures

Global Fibrinogen concentrates Market, By Regions

• North America

• Europe

• Asia-Pacific

• South America

• Middle East and Africa (MEA)

Key Players operating the Global Fibrinogen concentrates Market

• Baxter International Inc

• Csl Behring

• Green Cross International

• Harbin Pacific Biopharmaceutical Co Ltd

• Hualan Biological Engineering

• Jiangxi Boya Bio-Pharmaceutical

• Lfb Group

• Profibrix Bv

• Shanghai Raas

• Shanghai Xinxing Medicine Co Ltd

For More Information Vist:

Report Is Submitted By : Maximize Market Research Company 

Customization of the report:

Maximize Market Research of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info

Name: Lumawant Godage


 This Report Is Submitted By : Maximize Market Research Company

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908     8989132284



Please enter your comment!
Please enter your name here